TOMBERLI, ALESSIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 552
EU - Europa 454
AS - Asia 166
SA - Sud America 1
Totale 1.173
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 552
IT - Italia 120
IE - Irlanda 77
PL - Polonia 76
RU - Federazione Russa 68
SE - Svezia 68
HK - Hong Kong 57
CN - Cina 40
SG - Singapore 26
JO - Giordania 22
CH - Svizzera 14
VN - Vietnam 9
GB - Regno Unito 8
DE - Germania 5
FI - Finlandia 5
IN - India 5
RS - Serbia 5
PH - Filippine 4
ES - Italia 2
KR - Corea 2
UA - Ucraina 2
BE - Belgio 1
CL - Cile 1
FR - Francia 1
JP - Giappone 1
NL - Olanda 1
PT - Portogallo 1
Totale 1.173
Salva come PNG Salva come JPEG
Città #
Chandler 77
Dublin 77
Warsaw 73
Fairfield 70
Ashburn 53
Hong Kong 42
Florence 33
Seattle 32
Cambridge 29
Houston 29
Moscow 29
Woodbridge 29
New York 26
Wilmington 26
Lawrence 24
Altamura 21
Singapore 17
Buffalo 15
Princeton 15
Beijing 14
Bern 14
Shanghai 14
Boston 11
Naples 10
Prato 9
Dong Ket 8
Kent 7
Medford 7
Ann Arbor 6
Boardman 6
San Diego 6
Belgrade 5
Milan 5
Helsinki 4
Hillsboro 3
Quezon City 3
Andover 2
Anghiari 2
Cervia 2
Chennai 2
Duncan 2
Falls Church 2
Gubbio 2
Lecce 2
Los Angeles 2
Norwalk 2
Pontedera 2
Salerno 2
Seoul 2
Siena 2
Torremolinos 2
Vellore 2
Wandsworth 2
Amsterdam 1
Anguillara Sabazia 1
Bari 1
Breendonk 1
Bruino 1
Clifton 1
Genova 1
Grafing 1
Hanoi 1
Jinhua 1
Kilburn 1
Lappeenranta 1
London 1
Mem Martins 1
Nanjing 1
Palermo 1
Pavia 1
Prescot 1
Pune 1
Rome 1
San Miniato Basso 1
Santa Maria 1
Santiago 1
Sapporo 1
Scuola 1
Sestri Levante 1
Southwark 1
Staranzano 1
Tavarnuzze 1
Washington 1
Totale 913
Salva come PNG Salva come JPEG
Nome #
Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center 160
Long-term Outcomes of Pediatric-Onset Hypertrophic Cardiomyopathy and Age-Specific Risk Factors for Lethal Arrhythmic Events 110
Design of the SILICOFCM study: Effect of sacubitril/valsartan vs lifestyle intervention on functional capacity in patients with hypertrophic cardiomyopathy 83
Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): Prospective evaluation at a tertiary referral centre 77
Doctor-patient care relationship in genetic cardiomyopathies: An exploratory study on clinical consultations 75
Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy 73
Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy 69
Comprehensive Risk Management in Arrhythmogenic Cardiomyopathy Associated With Autosomal Dominant Carvajal Syndrome 68
Myocardial blood flow in patients with hypertrophic cardiomyopathy receiving perindopril (CARAPaCE): a pilot study 59
Targeted Medical Therapies for Hypertrophic Cardiomyopathy 53
Efficacy and safety of dysopiramide in patients with obstructive hypertrophic cardiomyopathy 47
Red flags for the diagnosis of cardiac amyloidosis: Simple suggestions to raise suspicion and achieve earlier diagnosis 46
Mavacamten, a Novel Therapeutic Strategy for Obstructive Hypertrophic Cardiomyopathy 43
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis 41
Clinical course and outcome of pregnancy in patients with hypertrophic cardiomyopathy 32
Prognostic value of cardiopulmonary exercise testing in patients with transthyretin cardiac amyloidosis 29
Genetic Testing and Counselling in Hypertrophic Cardiomyopathy: Frequently Asked Questions 24
Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring 24
Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis 22
Prevalence of anxiety and depression symptoms in a sample of outpatients with ATTR cardiac amyloidosis 20
Arrhythmic Burden in Cardiac Amyloidosis: What We Know and What We Do Not 18
Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center 18
Impact of Pregnancy on the Natural History of Women with Hypertrophic Cardiomyopathy 14
Real-World Use and Predictors of Response to Disopyramide in Patients with Obstructive Hypertrophic Cardiomyopathy 4
Totale 1.209
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.849
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.849
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020110 0 1 0 10 14 15 14 15 15 8 18 0
2020/2021206 14 4 10 29 10 11 20 14 21 45 16 12
2021/2022122 5 1 7 3 4 15 4 4 17 10 25 27
2022/2023399 27 85 18 24 26 57 57 22 42 10 13 18
2023/2024255 8 23 24 11 14 41 19 61 8 24 14 8
2024/202579 60 19 0 0 0 0 0 0 0 0 0 0
Totale 1.209